9 min read
IgA Nephropathy in 2026: From Supportive Care to Mechanism-Based Treatment
How KDIGO 2025 and recent phase 3 trials are reshaping risk assessment, proteinuria targets and disease-modifying treatment in IgA nephropathy.
Updates in Medicine
Clinical Reviews
Focused evidence reviews that connect emerging research with everyday clinical decisions.
18 min read
Diuretics in acute heart failure with rising creatinine: continue, reduce or stop?
How to distinguish a creatinine rise during effective decongestion from one that requires a change in treatment.
16 min read
Non-invasive ventilation in COPD exacerbations without hypercapnic respiratory failure: when is it justified?
Distinguishing patients who need medical treatment and observation from those requiring targeted respiratory support or urgent escalation.
15 min read
SBP Prophylaxis in Cirrhosis: Who Needs Primary vs Secondary Prevention — and When Should It Be Stopped?
Long-term antibiotics can prevent spontaneous bacterial peritonitis in selected patients with cirrhosis, but treatment and withdrawal decisions require careful risk–benefit assessment.
16 min read
Pulmonary Embolism in 2026: A Practical Approach to Diagnosis, Risk Stratification and Management
From clinical suspicion and D-dimer testing to the new AHA/ACC PE categories, anticoagulation, reperfusion therapy and follow-up.
11 min read
Heart Failure Classification in 2026: How the ESC Guidelines and Second Universal Definition Fit Together
Understanding stages, ejection-fraction phenotypes and changing disease trajectories without forcing false equivalence.
5 min read
Corticosteroids in ARDS in 2026: Who May Benefit and When?
A practical summary of current evidence on timing, clinical setting and patient selection.
8 min read
What’s new in valvular heart disease?
Earlier intervention, better phenotyping and lifetime planning are reshaping aortic, mitral and tricuspid valve care.